What does the evidence say about Mango Polyphenols Blood Pressure Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Mango Polyphenols Blood Pressure Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Background Low fruit intake is a global risk factor for cardiometabolic diseases. [Preiss C (2026); evidence level 4] - Other end points were generally not different between diets ( P >0.05), although select lipids and kidney markers were marginally different ( P P Conclusions In adults with prediabetes, daily inclusion of avocado and mango increases fruit consumption, diversifies nutrient composition, and improves vascular function associated with cardiovascular health. [Preiss C (2026); evidence level 4] - This study sought to investigate vascular and metabolic effects of increasing total and select fruit intake in adults with prediabetes. [Preiss C (2026); evidence level 4] - Results : Mango puree supplementation was associated with lower concentrations of C-reactive protein (mean difference: -1.6 mg/L; 95% CI: -2.1 to -1.1; p p = 0.003), and creatine kinase (-290.1 U/L; 95% CI: -356.1 to -224.1; p p p = 0.007) were higher during mango puree supplementation, while CD8+ T-cell percentage did not differ between conditions. [Parklak W (2026); evidence level 4] - Conclusions : Mango puree supplementation during regular training was associated with lower inflammatory and muscle damage biomarkers and alterations in selected T-cell subsets compared with the placebo. [Parklak W (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.